Midcap Value Alert: 3 Years of Subscription at the Price of 1
Here is the latest financial fact sheet of DECCAN HEALTH CARE. For more details, see the DECCAN HEALTH CARE quarterly results and DECCAN HEALTH CARE share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | -0.7 |
No. of shares | m | 20.38 |
1 Week | % | -9.2 |
1 Month | % | -15.5 |
1 Year | % | -16.3 |
52 week H/L | Rs | 42.0/23.1 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
DECCAN HEALTH CARE EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 142 | 115 | 53 | 39 | 51 | |
Low | Rs | 95 | 25 | 19 | 23 | 23 | |
Sales per share (Unadj.) | Rs | 28.2 | 26.9 | 21.5 | 21.1 | 26.4 | |
Earnings per share (Unadj.) | Rs | 9.2 | 6.4 | 0.2 | 0.2 | 0.2 | |
Diluted earnings per share | Rs | 7.1 | 5.0 | 0.2 | 0.2 | 0.2 | |
Cash flow per share (Unadj.) | Rs | 10.0 | 7.3 | 1.2 | 1.1 | 1.1 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 42.1 | 48.5 | 48.8 | 49.0 | 47.9 | |
Adj. book value per share | Rs | 32.5 | 37.4 | 37.6 | 37.8 | 40.0 | |
Shares outstanding (eoy) | m | 15.71 | 15.71 | 15.71 | 15.71 | 17.04 | |
Price / Sales ratio | x | 4.2 | 2.6 | 1.7 | 1.4 | 1.4 | |
Avg P/E ratio | x | 12.8 | 10.9 | 144.7 | 149.0 | 173.0 | |
P/CF ratio (eoy) | x | 11.8 | 9.6 | 30.4 | 26.8 | 35.2 | |
Price / Book Value ratio | x | 2.8 | 1.4 | 0.7 | 0.6 | 0.8 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 1,860 | 1,101 | 565 | 480 | 630 | |
Total wages/salary | Rs m | 41 | 43 | 29 | 22 | 32 |
DECCAN HEALTH CARE INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 442 | 422 | 338 | 332 | 450 | |
Other income | Rs m | 1 | 1 | 1 | 2 | 0 | |
Total revenues | Rs m | 443 | 423 | 338 | 334 | 450 | |
Gross profit | Rs m | 168 | 117 | 20 | 19 | 20 | |
Depreciation | Rs m | 13 | 14 | 15 | 15 | 14 | |
Interest | Rs m | 10 | 2 | 1 | 2 | 1 | |
Profit before tax | Rs m | 146 | 101 | 5 | 5 | 5 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 1 | 0 | 1 | 2 | 2 | |
Profit after tax | Rs m | 145 | 101 | 4 | 3 | 4 | |
Gross profit margin | % | 38.0 | 27.6 | 6.0 | 5.9 | 4.5 | |
Effective tax rate | % | 0.6 | 0.4 | 24.9 | 40.5 | 29.6 | |
Net profit margin | % | 32.7 | 23.9 | 1.2 | 1.0 | 0.8 |
DECCAN HEALTH CARE BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 571 | 659 | 665 | 680 | 759 | |
Current liabilities | Rs m | 136 | 136 | 127 | 105 | 120 | |
Net working cap to sales | % | 98.3 | 123.7 | 159.1 | 173.3 | 141.9 | |
Current ratio | x | 4.2 | 4.8 | 5.2 | 6.5 | 6.3 | |
Inventory Days | Days | 41 | 51 | 63 | 46 | 34 | |
Debtors Days | Days | 1,598 | 1,777 | 1,347 | 1,411 | 977 | |
Net fixed assets | Rs m | 258 | 271 | 258 | 227 | 210 | |
Share capital | Rs m | 157 | 157 | 157 | 157 | 170 | |
"Free" reserves | Rs m | 504 | 605 | 609 | 612 | 645 | |
Net worth | Rs m | 661 | 762 | 766 | 769 | 816 | |
Long term debt | Rs m | 9 | 9 | 7 | 10 | 12 | |
Total assets | Rs m | 829 | 930 | 923 | 906 | 969 | |
Interest coverage | x | 15.1 | 56.4 | 5.8 | 4.6 | 5.7 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 0.5 | 0.5 | 0.4 | 0.4 | 0.5 | |
Return on assets | % | 18.7 | 11.0 | 0.5 | 0.5 | 0.5 | |
Return on equity | % | 21.9 | 13.2 | 0.5 | 0.4 | 0.4 | |
Return on capital | % | 23.3 | 13.4 | 0.8 | 0.9 | 0.8 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx outflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
Net fx | Rs m | 0 | 0 | 0 | 0 | 0 |
DECCAN HEALTH CARE CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 26 | 27 | 2 | -6 | -66 | |
From Investments | Rs m | -115 | -19 | -1 | -0 | 3 | |
From Financial Activity | Rs m | 131 | -18 | -4 | 1 | 51 | |
Net Cashflow | Rs m | 42 | -10 | -2 | -6 | -12 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Minto Gupta | COMP SEC: Apeksha Baisakhiya | YEAR OF INC: 1996 | BSE CODE: 542248 | FV (Rs): 10 | DIV YIELD (%): - |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare DECCAN HEALTH CARE With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Asian share markets made a cautious start on Monday in a week where inflation figures could make or break hopes for earlier US rate cuts.